Safety and efficacy of sodium oligomannate in patients with Alzheimer’s disease: a systematic review and meta-analysis
Abstract Background We aim to evaluate the efficacy and safety of a new marine oligosaccharide drug, sodium oligomannate (GV-971), developed in China to treat Alzheimer’s disease (AD). Methods We researched the following databases: Embase, Web of Science, PubMed, Cochrane library, and Scopus until S...
Main Authors: | Anas Zakarya Nourelden, Ibrahim Kamal, Abdelrahman G. Tawfik, Abdulrahman Ibrahim Hagrass, Ahmed Hashem Fathallah, Mohamed Sayed Zaazouee |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-06-01
|
Series: | The Egyptian Journal of Neurology, Psychiatry and Neurosurgery |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41983-023-00682-y |
Similar Items
-
A phase II randomized trial of sodium oligomannate in Alzheimer’s dementia
by: Tao Wang, et al.
Published: (2020-09-01) -
Pharmacokinetics, distribution, and excretion of sodium oligomannate, a recently approved anti-Alzheimer's disease drug in China
by: Jiaojiao Lu, et al.
Published: (2022-02-01) -
Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner
by: Megan E. Bosch, et al.
Published: (2024-02-01) -
Sodium oligomannate combined with rivastigmine may improve cerebral blood flow and cognitive impairment following CAR-T cell therapy: A case report
by: Yan-Li Wang, et al.
Published: (2022-08-01) -
Small Farm Food Safety, Fresh Produce: Additional Resources for Participants Bringing Food Safety Concepts to Farms
by: Brian Lapinski, et al.
Published: (2007-11-01)